Skip to main content

Table 2 Additional objectives for the CompARE trial

From: CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Qualitative Recruitment Investigation (QRI) objectives

1. To monitor recruitment rates and identify sources of recruitment difficulties in the first year of the trial

2. To develop a plan to optimise randomisation and informed consent

Health economics objectives

1. To compare cost-effectiveness in all treatment arms through cost-utility analysis

2. To estimate the cost per quality-adjusted life years (QALY) over the 2-year period of the trial

Translational research (CompARE Collect) objectives

1. To prospectively collect and ‘bank’ high-quality tissue, saliva, and blood samples from patients with intermediate- and high- risk OPC

2. To develop and validate biomarker classifiers to aid better stratification of treatment selection

3. To develop several inter-related and complementary head and neck translational research projects